Apoptosis has an important role during development to regulate cell number. In differentiated cells, however, activation of autophagy has a critical role by enabling cells to remain functional following stress. In this study, we show that the antiapoptotic BCL-2 homologue MCL-1 has a key role in controlling both processes in a developmentally regulated manner. Specifically, MCL-1 degradation is an early event not only following induction of apoptosis, but also under nutrient deprivation conditions where MCL-1 levels regulate activation of autophagy. Furthermore, deletion of MCL-1 in cortical neurons of transgenic mice activates a robust autophagic response. This autophagic response can, however, be converted to apoptosis by either reducing the levels of the autophagy regulator Beclin-1, or by a concomitant activation of BAX. Our results define a pathway whereby MCL-1 has a key role in determining cell fate, by coordinately regulating apoptosis and autophagy.
Introduction
Macroautophagy (hereafter referred to as autophagy) is a catabolic process, in which portions of cytoplasm or organelles are delivered to lysosomes for bulk degradation (He and Klionsky, 2009; Mehrpour et al, 2010) . Autophagy is activated under starvation conditions in order to recycle the nutrients necessary for survival. A basal level of autophagy also exists in nutrient-replete cells to allow the turnover of damaged organelles and long-lived proteins (He and Klionsky, 2009; Mehrpour et al, 2010) . This basal autophagy is of particular importance in terminally differentiated cells, such as neurons, to prevent accumulation of damaged organelles and proteins (Germain and Slack, 2010) . Autophagy has indeed recently been suggested to have a major role in the elimination of protein aggregates associated with several neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. For example, deletion of two important autophagy regulatory proteins (ATG5 and ATG7) in the brain resulted in progressive accumulation of ubiquitinpositive protein aggregates, gradual loss of motor function and death of the animals within a few months of life (Hara et al, 2006; Komatsu et al, 2006) . Several studies have also shown that overexpression of autophagy genes or activation of autophagy by rapamycin leads to a reduction in aggregate formation in models of Alzheimer's, Huntington and Parkinson's disease (Ravikumar et al, 2004; Shibata et al, 2006; Pickford et al, 2008; Spencer et al, 2009) .
At the molecular level, autophagy is characterised by the formation of a double-membrane vesicle, the autophagosome, containing the material to be degraded (He and Klionsky, 2009; Mehrpour et al, 2010) . Autophagosomes subsequently fuse with lysosomes for bulk degradation. Autophagosome formation is regulated by a set of autophagy-related (ATG) genes that are conserved from yeast to mammals (Maiuri et al, 2007b; He and Klionsky, 2009 ). Autophagosome nucleation is regulated by a protein complex containing Beclin-1 and the PI3 kinase Vps34, while its elongation requires two ubiquitin-like conjugation systems that are dependent on the activity of ATG7: covalent association between ATG5 and ATG12, and lipidation of LC3 (Maiuri et al, 2007b; He and Klionsky, 2009 ). LC3 lipidation promotes its association with the autophagosome and is widely used as a marker of autophagy.
Apoptosis is a form of cellular suicide required for proper development of multicellular organisms that is controlled by BCL-2 homologues. Antiapoptotic (BCL-2, BCL-X L , A1, MCL-1) and proapoptotic (BAX, BAK) BCL-2 homologues regulate the permeability of the mitochondrial outer membrane. Activation of BH3-only proteins, the third group of BCL-2 homologues, is required for the activation of BAX/BAK, release of cytochrome c from the mitochondrial intermembrane space and subsequent activation of caspases, the apoptotic proteases (Youle and Strasser, 2008; Germain and Slack, 2010) . In addition to this well-characterised role in controlling apoptosis, BCL-2 homologues have recently been suggested to regulate autophagy (Pattingre et al, 2005; Maiuri et al, 2007a; Martin et al, 2009) . For example, BCL-2 and BCL-X L can both bind to Beclin-1 and inhibit its function (Pattingre et al, 2005; Maiuri et al, 2007a) , although the physiological significance of these interactions has not yet been demonstrated in the context of the whole animal. While there is increasing evidence of an interplay between apoptosis and autophagy (Boya et al, 2005; Pattingre et al, 2005; Maiuri et al, 2007a; Luo and Rubinsztein, 2010) , their relative importance in development and adult tissue, as well as the mechanisms by which BCL-2 homologues control the balance between these two cellular fates, remains to be determined.
In this study, we used genetic deletion of MCL-1 in postmitotic neurons to address these questions. We show that apoptosis and autophagy are differentially activated in vivo in neural progenitors and post-mitotic neurons, and that MCL-1 degradation lies upstream in a common pathway leading to both cell fates. In fact, a major outcome following MCL-1 degradation is autophagy unless BAX is concomitantly activated or autophagy inhibited, which then induces apoptosis. Altogether, these results indicate that MCL-1 coordinately regulates apoptosis and autophagy, the outcome being determined by the interplay between BAX and Beclin-1 activation downstream of MCL-1 degradation.
Results
MCL-1 is an antiapoptotic BCL-2 homologue that is rapidly degraded following stress, to allow apoptosis to proceed (Nijhawan et al, 2003) . More recently, we have shown that MCL-1 is one of the earliest BCL-2 family proteins to respond to stress following acute neuronal injury, before any sign of apoptotic signalling (Arbour et al, 2008) . Indeed, MCL-1 is degraded following glucose deprivation as a consequence of translation inhibition, and this occurs without signs of apoptosis (Mills et al, 2008; Pradelli et al, 2010) . Here, we confirmed these results in several cell types ( Figure 1 ) and, importantly, extended them to other forms of nutrient deprivation. For example, MCL-1 levels were dramatically decreased upon amino-acid starvation ( Figure 1A ; cells incubated in Earl's Balanced Salt Solution (EBSS)). Similarly, incubation of cerebellar granule neurons (CGNs) under hypoxic conditions (1% oxygen), or cortical neurons in the absence of glucose, led to a decrease in MCL-1 protein levels ( Figure 1B and C) , although the faster migrating isoform was decreased in cortical neurons ( Figure 1C ). Of note, protein levels of other BCL-2 homologues were not affected by nutrient starvation in either cell lines or cortical neurons ( Figure 1C ), indicating that this effect is specific to MCL-1. In addition, the decrease in MCL-1 protein levels was only transient, as MCL-1 levels returned to normal after reoxygenating hypoxic CGN for 4-8 h ( Figure 1B) , and within 1 h of reintroduction of glucose to cells that were incubated in glucose-free media for 3 h ( Figure 1D ), suggesting that MCL-1 degradation is not sufficient to induce apoptosis.
To directly address the consequences of MCL-1 degradation on apoptosis, we analysed the activation of BAX, a proapoptotic BCL-2 homologue that mediates cytochrome c release from mitochondria. While MCL-1 levels were reduced following a 3-h incubation of HeLa cells in EBSS ( Figure 1E , LacZ), similar to treatment with the apoptotic inducer camptothecin ( Figure 1E ), no BAX activation (as measured using the conformation-specific antibody 6A7) could be detected in EBSS-treated cells ( Figure 1F , LacZ). Accordingly, cytochrome c was retained in mitochondria of starved cells ( Figure 1G , LacZ), indicating that starvation-induced MCL-1 degradation does not activate the apoptotic cascade. This also suggests that a second, proapoptotic, signal is required to translate MCL-1 degradation into apoptosis. BAX activation is dependent on BH3-only proteins, and both classes of proapoptotic BCL-2 homologues are inhibited by MCL-1. Consequently, MCL-1 degradation (induced by starvation in this case) should enhance BH3-only protein-induced apoptosis. To test this, we infected HeLa cells with an adenovirus encoding the activated form of the BH3-only protein BID (Ad HA-tBID), which directly activates BAX without affecting MCL-1 levels ( Figure 1E ), in the presence of the pan-caspase inhibitor to prevent cells from lifting following cytochrome c release . tBID induced BAX activation and cytochrome c release in nutrient-replete cells ( Figure 1F and G). However, tBID-induced cytochrome c release was greater in starved cells ( Figure 1G ), despite lower tBID expression ( Figure 1E ), indicating that BAX activation following nutrient starvation leads to apoptosis. Altogether, these results indicate that MCL-1 levels are highly responsive to nutrient deprivation and that this does not directly result in the activation of apoptosis. (A) HeLa cells were incubated for 4 h in either EBSS or media without glucose/pyruvate. Lysates were then analysed by western blot for the presence of MCL-1, as well as actin as a loading control. (B) CGNs were subjected to 17 h hypoxia after 7 days in vitro. Protein lysates were collected at indicated times after reoxygenation and blotted for MCL-1 expression and for actin as a loading control. (C) H1299 cells stably expressing GFP-LC3 were incubated for 2 h in EBSS, and expression of various BCL-2 homologues was analysed by western blot. Alternatively, primary cortical neurons were incubated for 4 h in media without glucose/pyruvate. (D) H1299 cells stably expressing GFP-LC3 were incubated for 3 h in media without glucose/pyruvate, followed by re-addition of glucose and pyruvate for the indicated times. (E) HeLa cells were infected with 5 p.f.u. per cell of either Ad HA-tBID or Ad LacZ for 7 h, the media being changed to EBSS for the last 3 h where indicated. Alternatively, cells were treated with 50 mM camptothecin for 3 h. (F, G) HeLa cells were treated as in E in the presence of 50 mM zVAD-FMK and analysed by immunofluorescence for active BAX (6A7 epitope; F) or cyt c (G). Data are expressed as the average of three experiments±s.d. *Po0.01.
MCL-1 is degraded following induction of autophagy
The results presented above suggest that MCL-1 has a second, apoptosis-independent role in the regulation of cellular stress. A major response activated by nutrient deprivation under conditions that trigger MCL-1 degradation is autophagy. To address the physiological significance of MCL-1 degradation and establish a link between MCL-1 degradation and the induction of autophagy, we analysed the temporal relationship between MCL-1 loss and autophagosome formation. Conversion of a GFP-tagged version of the autophagy marker LC3 (GFP-LC3) from GFP-LC3-I to GFP-LC3-II, its translocation to punctate structures in the cytosol, as well as changes in levels of the LC3-associated protein p62 (which is degraded in the lysosomes under these conditions) have extensively been used to follow autophagy induction in cells. Incubation of H1299 cells stably expressing GFP-LC3 (H1299-LC3) (Chang et al, 2010) for up to 8 h in glucose-free media or in EBSS did not cause BAX activation or cytochrome c release (Figure 2A and B) , but induced loss of p62 protein, processing of GFP-LC3-I into GFP-LC3-II ( Figure 2C ) and appearance of LC3-positive structures in the cytosol ( Figure 2B ), indicative of autophagy induction. Under these conditions, loss of MCL-1 protein was an early event, as it occurred before LC3 processing and p62 degradation ( Figure 2D ).
MCL-1 regulates autophagy in cells
The observation that MCL-1 degradation is associated with activation of autophagy, but occurs before major changes in autophagy markers, suggests that MCL-1 degradation regulates autophagy initiation upstream of autophagosome formation. We took several approaches to test this possibility. First, to assess whether MCL-1 degradation lies upstream of autophagosome formation, MCL-1 levels were measured in the presence of 3-methyladenine (3MA), a class III PI3 kinase inhibitor that blocks autophagosome formation. However, while 3MA caused an increase in p62 levels under both basal and autophagic conditions, reflecting the inhibition of autophagy, it had no effect on MCL-1 degradation ( Figure 2E) . Similarly, the lysosomal inhibitor bafilomycin blocked p62 degradation, but had no effect on MCL-1 degradation ( Figure 2F ). Altogether, these results suggest that MCL-1 degradation occurs upstream of autophagosome formation, consistent with a possible regulatory function of MCL-1 in the initiation of autophagy.
We then addressed the function of MCL-1 degradation during autophagy. To preserve MCL-1 levels following induction of autophagy, MCL-1 was overexpressed in H1299-LC3 cells using an adenovirus. Overexpression of MCL-1 decreased the number of GFP-LC3 foci (autophagosomes) ( Figure 3A ). The total surface area occupied by GFP-LC3 vesicles was also quantified, showing a significant decrease in vesicle formation in MCL-1-overexpressing cells ( Figure 3B ). Cells overexpressing MCL-1 also had increased basal levels of p62, while p62 degradation was reduced in Ad MCL-1-starved cells compared with control infection (Ad LacZ; Figure 3E ). These results indicate that increased MCL-1 levels block autophagy.
As these experiments were consistent with an inhibitory role of MCL-1 on the initiation of autophagy, we tested the effect of MCL-1 loss on the autophagic response. Compared with control siRNA, MCL-1 levels were decreased by B70% in cells transfected with MCL-1 siRNA ( Figure 3F ). Downregulation of MCL-1 greatly increased the formation of GFP-LC3-positive vesicles ( Figure 3A and B), as well as the lipidation of endogenous LC3 ( Figure 3C and D). In addition, MCL-1 knockdown resulted in a 50% decrease in p62 levels in cells grown in complete media and a further decrease when cells were grown in glucose-free media for 3 h ( Figure 3F ). Similarly, MCL-1 knockdown increased processing of GFP-LC3I to GFP-LC3II following starvation, and also caused the accumulation of cleaved GFP (generated through lysosomal degradation of GFP-LC3; Klionsky et al, 2008) even in nutrient-replete cells ( Figure 3F ). Of note, none of these manipulations caused cytochrome c release or BAX activation for up to 4 h (Figures 2A and 3A) , although some activation of apoptosis was observed at later time points (o10% of the cells at 8h; Figure 2A ) when MCL-1 was acutely depleted before starvation rather than as a normal consequence of starvation. Altogether, these results support the conclusion that loss of MCL-1 is not sufficient to induce apoptosis even under starvation conditions.
The role of MCL-1 in the regulation of autophagy was also studied in primary cortical neurons from MCL-1 flox/flox animals, in which MCL-1 was removed in vitro using a lentiviral vector expressing the Cre recombinase. Consistent with the siRNA results, ablation of MCL-1 in primary neurons caused a marked decrease in p62 levels ( Figure 3G ). Similarly, an increase in endogenous LC3-II was observed in SV40-transformed MCL-1-null MEFs ( Figure 3H ). Taken together, these results indicate that MCL-1 negatively regulates autophagy, and that its degradation is required for autophagy to proceed.
One potential explanation for the increase in autophagosomes observed following loss of MCL-1 is the failure of autophagosome fusion with lysosomes, thus resulting in their accumulation. To test this possibility, we further studied the effect of MCL-1 on the fusion between GFP-LC3 vesicles and lysosomes. A fraction of GFP-LC3 vesicles colocalised with the lysosomal marker LAMP1 in EBSS-treated control cells and the percentage of GFP-LC3 vesicles that colocalised with LAMP1 was not affected by overexpression or downregulation of MCL-1 ( Figure 3J ; quantified in Figure 3I ), indicating that MCL-1 does not affect the fusion between autophagosomes and lysosomes. Accordingly, inhibition of lysosomal function with bafilomycin increased endogenous LC3-II levels in both control and MCL-1 knockdown cells (Figure 3C and D) . This is consistent with the accumulation of cleaved GFP observed following MCL-1 downregulation. These findings, together with the observation that MCL-1 degradation is upstream of autophagosome formation, suggest that MCL-1 serves as an early regulator of autophagy in cells exposed to nutrient deprivation, its effects being proportional to the strength of the autophagic stimulus.
BCL-2 and BCL-X L inhibit autophagy by blocking the function of Beclin-1 (Pattingre et al, 2005; Maiuri et al, 2007a) , a key upstream regulator of autophagy (He and Klionsky, 2009 ). MCL-1 was also reported to interact with GST-tagged Beclin-1 (Erlich et al, 2007) , an observation that we have extended to the endogenous proteins ( Figure 4A ). This, along with the observation that MCL-1 inhibits autophagy caused by overexpression of Beclin-1 (Maiuri et al, 2007a) , suggests that, similar to BCL-2 and BCL-X L , MCL-1 regulates autophagy at least in part by controlling the activity of Beclin-1. Interestingly, while the functional interaction between BCL-2 and Beclin-1 occurs at the endoplasmic reticulum, where both proteins partially localise (Pattingre et al, 2005) (Figure 4B ), MCL-1 is absent from this organelle ( Figure 4B ). Rather, MCL-1 is a mitochondrial protein (Chou et al, 2006; Germain and Duronio, 2007) in which Beclin-1 also partially localises ( Figure 4B ) (Pattingre et al, 2005; Maiuri et al, 2007a) , suggesting that MCL-1 interacts with Beclin-1 on mitochondria. To directly test this possibility, cells were fractionated into HM containing mitochondria and LM containing ER, and MCL-1 was immunoprecipitated. As shown in Figure 4C , Beclin-1 co-precipitated with MCL-1 only in the fraction containing mitochondria, indicating that the two proteins interact at the mitochondria and not the ER.
Neuron-specific deletion of MCL-1 deregulates activation of autophagy
At the level of the organism, previous studies have indicated that autophagy has an important role in the homeostasis of the central nervous system (CNS). For example, deletion of key autophagy regulators (ATG5, ATG7) in the CNS leads to progressive accumulation of ubiquitin-containing aggregates and neurodegeneration (Hara et al, 2006; Komatsu et al, 2006) , whereas deletion of Ambra1, a component of the Beclin-1/Vps34 complex, causes major neural tube defects (Fimia et al, 2007) . To determine whether MCL-1 regulates autophagy in the CNS, we examined the consequences of MCL-1 deletion in post-mitotic cortical neurons. Mice homozygous for a floxed MCL-1 allele (MCL-1 flox/flox ) were crossed with animals carrying a CamKIIa Cre transgene, resulting in the expression of the Cre recombinase in neurons of the cortex, hippocampus and, to a lesser extent, striatum (Casanova et al, 2001) . MCL-1 D/D mice were born at the expected ratio, but were smaller in size ( Figure 5A ) and had a median lifespan of 49 days, with a few animals surviving to 3 months (see Figure 8E) . Recombination of the floxed alleles was confirmed by western blot of tissue from the cortex of P14 animals ( Figure 5B ). No change in protein expression was observed for BAX and BCL-X L ( Figure 5B ), suggesting that there were little compensatory changes in these other BCL-2 homologues highly expressed in the brain. Cresyl violet staining of brain sections revealed progressive cellular loss in cortical layers adjacent to the corpus callosum in MCL-1 D/D animals, with extensive loss evident by P14 ( Figure 5C ). As we hypothesised that MCL-1 loss would result in increased autophagy, we measured several autophagic markers in MCL-1 D/D mice. Brain sections from control and MCL-1 D/D mice were stained for endogenous LC3, which appears as punctate staining in the cytosol of autophagic cells. As shown in Figure 5E , LC3-positive cells lined the cortical region where cell loss was observed in P14 MCL-1 D/D animals, while minimal staining was present in control mice. Higher magnification images of the affected region confirmed punctate LC3 staining in cells of mutant, but not control animals ( Figure 5G ; quantification in Figure 5D ). Co-staining with the neuronal marker NeuN confirmed that neurons, but not glia, were affected ( Figure 5H ). To further substantiate these results, the cortex of P14 control and MCL-1 D/D mice was examined by electron microscopy. Compared with control, multiple vesicles containing portions of cytoplasm, including mitochondria, were present in the cortex of MCL-1 D/D mice (Figure 5F and I; asterisks denote autophagosomal structures; arrows denote mitochondria). These structures were delineated by a double membrane, indicative of autophagosomes ( Figure 5I , arrowheads point to the double membrane). As accumulation of autophagosomes could reflect a decrease in their clearance, we also determined p62 levels in MCL-1 D/D brains as a measure of lysosomal degradation of autophagosomes. As shown in Figure 6A , p62 levels were decreased in MCL-1
cortical extracts, suggesting that loss of MCL-1 does not prevent lysosomal degradation of the autophagosomes. Altogether, these results indicate that the deletion of MCL-1 in cortical neurons results in the deregulated activation of autophagy.
In addition to its role in the regulation of autophagy, MCL-1 has a well-characterised antiapoptotic role during development, including in the CNS (Opferman et al, 2003 (Opferman et al, , 2005 Arbour et al, 2008) . To determine whether MCL-1 has a similarly important antiapoptotic role in post-mitotic neurons, we analysed MCL-1 D/D mice for the presence of apoptotic markers. The activated form of BAX (6A7-reactive) and caspase-3 were first detected at P7 in MCL-1 D/D mice and were increased by P14 ( Figure 6B ), suggesting that apoptosis is activated to some extent in these animals. To determine the relationship between autophagy and apoptosis activation, we further analysed BAX activation in relation to LC3 staining. In P7 MCL-1 D/D mice, virtually all (97 ± 3%) NeuN-positive neurons were also positive for LC3 ( Figure 5H ), while only 18 ± 5% of the cells were positive for active BAX ( Figure 6B ). These BAX-positive cells are neurons with activated autophagy, as they co-stained with LC3 ( Figure 6C ). In addition, while there are no new cortical neurons generated after birth, the number of LC3-positive neurons decreased at P14 compared with P7 with a concomitant increase in both active BAX and active caspase-3-positive cells that paralleled cellular loss. This suggests that a subset of the neurons that initially activate autophagy in response to MCL-1 deletion undergo apoptosis over time, although we cannot exclude the possibility that apoptosis and autophagy are concomitantly activated in this subset of neurons. Nevertheless, the idea that autophagic MCL-1 KO neurons eventually activate apoptosis is supported by the observation that while all BAX-positive cells were also positive for LC3 at P7, a portion of these cells (8%) was LC3-negative by P14 ( Figure 6C ; quantification in Figure 8D ), in accordance with the notion that apoptosis can inhibit autophagy (Luo and Rubinsztein, 2010) . To further examine the effect of MCL-1 loss on apoptosis in post-mitotic neurons in a system where dying cells are more readily tractable, we deleted MCL-1 from MCL-1 flox/flox neurons in culture, which activates an autophagic response ( Figure 3G ), and analysed the cells for the presence of apoptotic markers. There was no increase in apoptosis in MCL-1 knockout neurons compared with control neurons for up to 10 days in culture, as determined by caspase-3-dependent cleavage of p130 CAS into a 31 kDa fragment (Kook et al, 2000) ( Figure 6D ) and cytochrome c release ( Figure 6E ). Altogether, these results suggest that the primary cellular response to MCL-1 deletion in neurons is the induction of autophagy, consistent with our results in cell lines (Figures 1-3) .
Regulation of apoptosis and autophagy by MCL-1 is dependent on the developmental stage in the CNS
We previously reported an increase in apoptosis when MCL-1 was deleted in neuronal progenitors (using Foxg1 and Nestin Cre promoters), both in vivo and in neural progenitor cultures (Arbour et al, 2008) . This suggests that the cellular context dictates the final outcome following degradation of MCL-1. To test this possibility, we first examined whether colocalised with the lysosomal marker LAMP1 did not differ between the cortex and the VZ ( Figure 7C ), these results suggest that the autophagic machinery is upregulated as neurons differentiate, consistent with the autophagic response observed in MCL-1 D/D neurons.
To determine whether post-mitotic neurons and neural progenitors express a different complement of apoptotic and autophagic genes, cortical neurons and neurospheres (neural progenitors) were cultured from E14.5 embryos. There was a marked difference in the expression of proapoptotic and autophagy-related proteins between progenitors and postmitotic neurons ( Figure 7D ). For example, expression of the BH3-only proteins BIM and Puma was higher in neurospheres. Conversely, ATG7 and the ATG5-ATG12 conjugate, two important autophagy regulatory proteins, were expressed at higher levels in neurons ( Figure 7D ). This suggests that autophagy and apoptosis are differentially regulated as neurons differentiate, consistent with the pattern of LC3 staining observed in E15.5 embryos. As a control, the purity of the cultures was assessed by blotting for the neuronal marker Tuj-1 and the progenitor marker Nestin ( Figure 7D ). As BH3-only proteins are required for BAX activation, a key step in determining cell fate downstream of MCL-1 degradation (Figure 1 ), these differences suggest that neural progenitors have a higher propensity than neurons to undergo apoptosis under low-nutrient conditions. This was tested by measuring apoptosis and autophagy in EBSS-treated neurospheres and neurons. We first verified that starvation caused MCL-1 degradation in neurospheres ( Figure 7E ). While both neurons and neurospheres had increased LC3-II levels following induction of autophagy, only neurospheres showed an increase in apoptosis, as evaluated by p130 CAS cleavage and cytochrome c release ( Figure 7F and G) . This indicates that neural progenitors are more susceptible than neurons to apoptosis following nutrient deprivation.
Inhibition of autophagy activates apoptosis in CamKIIa
Cre MCL-1 knockout Altogether, these results indicate that neurons, as long-lived post-mitotic cells, preferentially respond to stress by activating autophagy rather than apoptosis, in an attempt to restore homeostasis. Thus, inhibiting autophagy in neurons should drive these cells towards an apoptotic response. To test this hypothesis, MCL-1 D/D mice were crossed with mice deficient for Beclin-1, as it is an essential autophagy protein regulated by MCL-1 (Figure 4 ; Maiuri et al, 2007a) . As homozygous deletion of Beclin-1 is embryonically lethal, we examined Beclin-1 þ /À animals, which have a 30-50% reduction in autophagy (Qu et al, 2003; Yue et al, 2003) . MCL-1
Beclin-1 þ /À mice were born at the expected ratio, but started to die around 2 weeks of age ( Figure 8E Figure 8A ). To determine the extent of apoptosis, brain sections from each genotype were stained for active BAX (6A7) and active caspase-3. The number of cells positive for active BAX and active caspase-3 was significantly increased in MCL-1 Figure 8B and C) . Moreover, the number of 6A7-positive, LC3-negative cells was doubled in MCL-1 Figure 8D ). This suggests that a greater proportion of neurons activate apoptosis when Beclin-1 levels are reduced, consistent with previous reports on the relationship between apoptosis and autophagy in stressed cells in culture (Boya et al, 2005; Luo and Rubinsztein, 2010) . Altogether, our results suggest that MCL-1 functions as an upstream regulator of a stressresponse pathway controlling both apoptosis and autophagy in a developmentally regulated manner.
Discussion
Apoptosis is a critical process regulating development of multicellular organisms. However, while neural precursors readily induce apoptosis following stress, neurons are more resistant and use autophagy as a mechanism to dispose of damaged cellular components. This context-dependent regulation of apoptosis and autophagy is controlled by MCL-1, an antiapoptotic BCL-2 homologue with a very short half-life. In fact, we show here that MCL-1 levels regulate autophagy, both in cells in culture and in post-mitotic neurons.
Deletion of MCL-1 in several systems, including haematopoietic precursors, liver and neuronal progenitors, leads to activation of apoptosis, resulting in cellular loss (Opferman et al, 2003 (Opferman et al, , 2005 Arbour et al, 2008; Weber et al, 2010) . In contrast, we show here that autophagy is an important cellular outcome following deletion of MCL-1 in post-mitotic neurons. This is supported by the observation that virtually all neurons (stained with NeuN) are positive for LC3 in P7 mice ( Figure 5H ), while all BAX-positive cells are also LC3-positive at that age ( Figure 6C ). In addition, in vitro deletion of MCL-1, a setting in which apoptotic cells are not rapidly removed, did not induce any apoptosis in cortical neurons over wild-type levels, even after 10 days ( Figure 6D and E). These data support our interpretation that MCL-1 deficiency induces a robust autophagic response in mature neurons.
The outcome of the deletion of MCL-1 in neuronal precursors and post-mitotic neurons also supports a model in which MCL-1 coordinately regulates apoptosis and autophagy in a context-dependent manner. For example, postmitotic neurons display a greater amount of autophagyrelated proteins and primarily activate autophagy when starved. In contrast, a portion of neural precursors, which express higher levels of proapoptotic proteins than neurons, activate apoptosis in response to the same stress. The relationship between apoptosis and autophagy is however complex, as autophagy deficiency renders cells more susceptible to apoptosis while apoptosis inhibits autophagy (Boya et al, 2005; Luo and Rubinsztein, 2010) . In that context, it is noteworthy that MCL-1 knockout neurons could be forced to undergo apoptosis by decreasing the levels of the autophagy regulator Beclin-1. Conversely, tBID-dependent activation of BAX in starved HeLa cells pushed these cells towards apoptosis. On the basis of these findings, we propose the following model for the coordinated regulation of apoptosis and autophagy by MCL-1 ( Figure 8F ). Cellular stress causes the degradation of MCL-1, relieving its inhibitory effect on both autophagy (Beclin-1) and apoptosis (BAX). However, other signals are required for complete activation of either pathway. These additional autophagy or apoptosis-specific signalling pathways become activated by cellular stress, as a consequence of both the nature of the stress and the cellular context. Of note, MCL-1 localises to mitochondria where it interacts with Beclin-1, whereas BCL-2 functionally interacts with Beclin-1 at the ER. Given that both ER (Axe et al, 2008) and mitochondria (Hailey et al, 2010) have recently been suggested to provide lipids for autophagosome formation, MCL-1 could be required to regulate the mitochondrial pathway of autophagosome formation.
Regulation of the balance between autophagy and apoptosis is critical during development, as both processes have an important role. For example, deletion of the autophagy regulator Ambra-1 causes unbalanced cell proliferation and excessive apoptotic cell death during neuronal development, leading to severe neural tube defects (Fimia et al, 2007) . On the other hand, deletion of key components of the mitochondrial pathway of apoptosis results in brain overgrowth (reviewed in Ranger et al (2001) ). In addition, the regulation of both processes has a crucial role in the outcome of several pathological conditions, such as neurodegenerative diseases and cancer. In the case of neurodegenerative diseases, while maintaining a basal level of autophagy to dispose of damaged organelles or proteins is critical for survival, strong induction of autophagy could lead to cell death (Germain and Slack, 2010) . This could potentially be as a consequence of the clearance of mitochondria or other organelles (Xue et al, 2001) or, as our results suggest in the case of MCL-1, because sustained activation of autophagy activates an apoptotic response.
Several pathways have previously been shown to cause MCL-1 degradation. First, the ubiquitin ligases Mule and TRCP ubquitinate MCL-1 and promote its degradation (Warr et al, 2005; Zhong et al, 2005; Maurer et al, 2006; Ding et al, 2007) . Interestingly, MCL-1 degradation caused by serum withdrawal is the consequence of GSK3-dependent recruitment of TRCP (Ding et al, 2007) . Ubiquitination of MCL-1 by these two E3 ligases has, however, been linked to apoptosis. More recently, MCL-1 transcription has been shown to be regulated by mTOR, the key regulator of transcription that is inactivated following nutrient starvation (Mills et al, 2008; Pradelli et al, 2010) . It is thus likely that MCL-1 degradation following nutrient starvation is the direct consequence of mTOR inhibition, as recently suggested. In any case, the position of MCL-1 as an upstream stresssensitive protein coordinately regulating apoptosis and autophagy renders MCL-1 a key regulator of cell fate under stress conditions.
Materials and methods
Cell culture, transfections and infections H1299 cells stably expressing GFP-LC3 (gift from Dr Gordon Shore, McGill University), HeLa cells and MEFs were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. For the induction of autophagy, cells were washed in PBS and incubated for the indicated time in either EBSS(Sigma) or DMEM, containing no glucose or pyruvate supplemented with 10% fetal bovine serum. Where indicated, cells were pre-treated 1 h with 3MA (5 mM) or Bafilomycin (200 nM) before inducing autophagy. Infections with an adenoviral vector coding for myc-tagged MCL-1 or HA-tBID (gift from Gordon Shore) were carried out as described . For the siRNA experiments, cells were transfected with 50 nM Ctrl or MCL-1 siRNA (Santa Cruz Biotechnology) using SilentFect (Bio-Rad Laboratories) and analysed after 24 h. Subcelular fractionation was carried as described (Germain et al, 2002) .
Neurospheres, cortical neurons and CGNs were cultured as described previously (Cregan et al, 1999; Fortin et al, 2001; Vanderluit et al, 2004) . For immunofluorescence, neurosphere were grown on coverslips for 2 days in neurobasal containing 0.5 mM L-glutamine, 1% N2 supplement, 2% B27 supplement, 10 ng/ml bFGF and 20 ng/ml EGF. Where indicated, neurons were infected at the time of plating with a lentiviral vector expressing the Cre recombinase using an MOI of 2. Hypoxic cell death was induced using a humidified environmental chamber (Coy Laboratory, Grass Lake, MI) set at 371C. Oxygen concentration was maintained at 1% with a calibrated gas mixture of 95% nitrogen and 5% carbon dioxide. CGN cultures were treated with 10 mM cytosine-arabinoside after 2 days in vitro to inhibit glial growth, and incubated in the chamber after 7-8 days in vitro for 16-18 h at 1% oxygen in the presence of the NMDA receptor blocker, MK801 (10 mM). Cultures were then allowed to reoxygenate by incubating under normoxic conditions at 371C. Cells were collected at the indicated times following reoxygenation.
Antibodies and immunoblots
The following antibodies were used: mouse anti-mtHSP70 (ABR Bioreagents); mouse anti-HSC70 (Abcam); mouse anti-Tuj-1 (Gift from Dr Dave Brown); mouse anti-Nestin (Research Diagnostics Inc.); guinea-pig anti p62 (Progen Biotechnik); rabbit anti-mouse MCL-1 (Rockland Immunochemicals); rat anti-APAF-1 and mouse anti-NeuN (Chemicon); rabbit anti-human MCL-1, mouse antihuman p62, rabbit anti-mouse p62, rabbit anti-Beclin-1, rabbit anti-ATG-7, mouse anti-BCL-X, mouse anti-human LAMP1 and rabbit anti-BAX (Santa Cruz Biotechnology); mouse anti-GFP (Clonetech), mouse anti-actin (Sigma); rabbit anti-LC3 and rabbit anti-ATG5 (Novus Biologicals); mouse anti-mouse p62, mouse anti-cytochrome c, rabbit anti-BIM, mouse anti-BCL-2, mouse anti-active BAX (6A7), mouse anti-calreticulin (BD Pharmingen); rabbit anti-BAK (Upstate); rabbit anti-BCL-W, rabbit anti-HA, rabbit anti-PUMA and rabbit anti-active caspase-3 (Cell Signaling Technology). Cells were lysed in 10 mM Tris-HCl, pH 7.9, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 supplemented with a protease inhibitor mixture (Sigma-Aldrich). For immunoprecipitation, lysates were incubated for 2 h with the antibody and precipitated with protein G-Sepharose. For immunoblot analysis, proteins were subjected to SDS-PAGE, transferred to nitrocellulose membranes, and blotted with specific antibodies. Blots were incubated with horseradish peroxidaseconjugated secondary antibodies and visualised by enhanced chemiluminescence (Amersham Biosciences).
Immunofluorescence
For immunofluorescence, cells were grown on coverslips and treated as indicated in the figure legends. Cells were then fixed with 4% paraformaldehyde (PFA) and analysed by immunofluorescence using AlexaFluor secondary antibodies (Molecular Probes). All images were taken using a Zeiss 510 meta confocal microscope. Quantification of GFP-LC3 staining was performed by calculating the surface area of the GFP-LC3 fluorescence above a set threshold (that was kept constant throughout the experiments) over the total surface area of the cell, using the Image J software.
Animals
All experiments were approved by the University of Ottawa's Animal Care Ethics Committee adhering to the Guidelines of the Canadian Council on Animal Care. To generate forebrain-specific MCL-1 KO mice, the previously described floxed MCL-1 mice were crossed with CamKIIa Cre mice (Casanova et al, 2001) . MCL-1 mice were also crossed with Beclin-1 þ /À mice (gift from Dr Beth Levine). All mice were kept on a C57Bl/6 background. Animals were genotyped according to standard protocols with previously published primers for MCL-1 Beclin-1 and Cre.
Tissue processing and immunohistochemistry
Mice were euthanised with a lethal injection of sodium pentobarbitol. For immunohistochemistry, mice were perfused with 1 Â PBS followed by cold 4% PFA. Brains were then removed, post-fixed overnight in 4% PFA, cryoprotected in 20% sucrose in 1 Â PBS, and frozen. Sections were collected as 14 mm coronal cryosections on Superfrost Plus s slides (Fisher Scientific). For western blot analysis, brains were removed, cortices dissected and flash-frozen in liquid nitrogen. For EM, mice were perfused with a combination of 2% PFA and 2% glutaraldehyde. Pieces of cortex not 41 mm 2 were taken and processed as described (Cheung et al, 2006) .
Statistical analysis
Statistical differences were determined using Student's t-test or one-way ANOVA. Po0.05 was considered statistically significant.
